ProMIS Neurosciences congratulates Biogen on FDA accelerated approval of aducanumab for Alzheimer’s disease – GlobeNewswire

ProMIS Neurosciences congratulates Biogen on FDA accelerated approval of aducanumab for Alzheimer’s disease – GlobeNewswire
Source: Google NewsPublished on 2021-06-08